List of Tables
Table 1. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Specialty Active Pharmaceutical Ingredients Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Specialty Active Pharmaceutical Ingredients Covered in This Study
Table 5. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers (2016-2021)
Table 7. Global Specialty Active Pharmaceutical Ingredients Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Specialty Active Pharmaceutical Ingredients Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Specialty Active Pharmaceutical Ingredients Manufacturing Sites and Area Served
Table 11. Manufacturers Specialty Active Pharmaceutical Ingredients Product Type
Table 12. Global Specialty Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Specialty Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Specialty Active Pharmaceutical Ingredients Sales by Region (2016-2021) & (K MT)
Table 16. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
Table 17. Global Specialty Active Pharmaceutical Ingredients Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (K MT)
Table 19. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 20. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 22. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (K MT)
Table 23. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 24. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
Table 30. Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 32. Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2016-2021)
Table 38. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Type (2016-2021)
Table 39. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2016-2021)
Table 40. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) by Type (2016-2021)
Table 41. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2016-2021)
Table 42. Global Specialty Active Pharmaceutical Ingredients Price (USD/MT) by Type (2016-2021)
Table 43. Global Specialty Active Pharmaceutical Ingredients Sales (K MT) by Application (2016-2021)
Table 44. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2016-2021)
Table 45. Global Specialty Active Pharmaceutical Ingredients Revenue (Million US$) by Application (2016-2021)
Table 46. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Application (2016-2021)
Table 47. Global Specialty Active Pharmaceutical Ingredients Price (USD/MT) by Application (2016-2021)
Table 48. Sanofi Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Sanofi Specialty Active Pharmaceutical Ingredients Product
Table 52. Sanofi Recent Developments/Updates
Table 53. Cambrex Corporation Information
Table 54. Cambrex Description and Business Overview
Table 55. Cambrex Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Cambrex Specialty Active Pharmaceutical Ingredients Product
Table 57. Cambrex Recent Developments/Updates
Table 58. Almac Corporation Information
Table 59. Almac Description and Business Overview
Table 60. Almac Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Almac Specialty Active Pharmaceutical Ingredients Product
Table 62. Almac Recent Developments/Updates
Table 63. Johnson Matthey Corporation Information
Table 64. Johnson Matthey Description and Business Overview
Table 65. Johnson Matthey Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Johnson Matthey Specialty Active Pharmaceutical Ingredients Product
Table 67. Johnson Matthey Recent Developments/Updates
Table 68. PolyPeptide Corporation Information
Table 69. PolyPeptide Description and Business Overview
Table 70. PolyPeptide Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. PolyPeptide Specialty Active Pharmaceutical Ingredients Product
Table 72. PolyPeptide Recent Developments/Updates
Table 73. AmbioPharm Corporation Information
Table 74. AmbioPharm Description and Business Overview
Table 75. AmbioPharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. AmbioPharm Specialty Active Pharmaceutical Ingredients Product
Table 77. AmbioPharm Recent Developments/Updates
Table 78. Avecia Corporation Information
Table 79. Avecia Description and Business Overview
Table 80. Avecia Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Avecia Specialty Active Pharmaceutical Ingredients Product
Table 82. Avecia Recent Developments/Updates
Table 83. ST Pharm Corporation Information
Table 84. ST Pharm Description and Business Overview
Table 85. ST Pharm Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. ST Pharm Specialty Active Pharmaceutical Ingredients Product
Table 87. ST Pharm Recent Developments/Updates
Table 88. Biospring Corporation Information
Table 89. Biospring Description and Business Overview
Table 90. Biospring Specialty Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Biospring Specialty Active Pharmaceutical Ingredients Product
Table 92. Biospring Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Specialty Active Pharmaceutical Ingredients Distributors List
Table 96. Specialty Active Pharmaceutical Ingredients Customers List
Table 97. Specialty Active Pharmaceutical Ingredients Market Trends
Table 98. Specialty Active Pharmaceutical Ingredients Growth Drivers
Table 99. Specialty Active Pharmaceutical Ingredients Market Restraints
Table 100. Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Type (2022-2027) & (K MT)
Table 101. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Application (2022-2027) & (K MT)
Table 105. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Region (2022-2027) & (K MT)
Table 109. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Specialty Active Pharmaceutical Ingredients
Figure 2. Global Specialty Active Pharmaceutical Ingredients Market Share by Type in 2020 & 2027
Figure 3. Steroidal API Product Picture
Figure 4. Peptide API Product Picture
Figure 5. Carbohydrate API Product Picture
Figure 6. Small Molecule API Product Picture
Figure 7. High Potency AP Product Picture
Figure 8. Global Specialty Active Pharmaceutical Ingredients Market Share by Application in 2020 & 2027
Figure 9. CNS
Figure 10. Cardiovascular
Figure 11. Genitourinary/Hormonal Drugs
Figure 12. Rheumatology
Figure 13. Diabetes
Figure 14. Oncology
Figure 15. Others
Figure 16. Global Specialty Active Pharmaceutical Ingredients Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Specialty Active Pharmaceutical Ingredients Market Size 2016-2027 (US$ Million)
Figure 18. Global Specialty Active Pharmaceutical Ingredients Sales 2016-2027 (K MT)
Figure 19. Global Specialty Active Pharmaceutical Ingredients Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers in 2020
Figure 21. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Specialty Active Pharmaceutical Ingredients Players: Market Share by Revenue in 2020
Figure 23. Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2016-2021)
Figure 25. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2020
Figure 26. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
Figure 27. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2020
Figure 28. U.S. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Taiwan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Philippines Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Vietnam Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Mexico Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Brazil Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Argentina Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Turkey Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. U.A.E Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Sales Market Share of Specialty Active Pharmaceutical Ingredients by Type (2016-2021)
Figure 53. Sales Market Share of Specialty Active Pharmaceutical Ingredients by Application (2016-2021)
Figure 54. Sales Market Share of Specialty Active Pharmaceutical Ingredients by Application in 2020
Figure 55. Revenue Share of Specialty Active Pharmaceutical Ingredients by Application (2016-2021)
Figure 56. Revenue Share of Specialty Active Pharmaceutical Ingredients by Application in 2020
Figure 57. Manufacturing Cost Structure of Specialty Active Pharmaceutical Ingredients
Figure 58. Manufacturing Process Analysis of Specialty Active Pharmaceutical Ingredients
Figure 59. Specialty Active Pharmaceutical Ingredients Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

LIST OF FIGURE